Back to search

Article

Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors

2018-08-29

Abstract excerpt

<h4>ABSTRACT</h4> Trisomy 21 (T21) causes Down syndrome (DS), affecting immune and neurological function by unknown mechanisms. We report here the results of a large metabolomics study showing that people with DS produce elevated levels of kynurenine and quinolinic acid, two tryptophan catabolites with potent immunosuppressive and neurotoxic properties, respectively. We found that immune cells of people with DS o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e280a38e-86f8-5ded-ba38-ac179110b604
DOI
10.1101/403642
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptorsDOI 10.1101/403642
Select a neighboring publication to make it the new centre.